Summary
AI-enabled analysis of histopathology images demonstrated the ability to accurately predict homologous recombination deficiency (HRD) without relying on traditional genomic testing. Advanced machine learning and deep learning models extracted image-derived features associated with DNA repair pathway deficiencies, enabling non-invasive inference of tumor molecular characteristics. This approach reduces dependency on costly molecular assays while accelerating diagnostic workflows. Integration of AI-driven digital pathology with clinical diagnostics enables scalable screening for HRD across large patient populations, supporting precision oncology and personalized treatment selection.
Read Abstract
Key Findings:-
- AI-based histopathology analysis can detect HRD directly from tissue images without genomic sequencing.
- Image-derived features serve as indicators of DNA repair pathway deficiencies.
- HRD prediction enables identification of patients suitable for PARP inhibitors and combination therapies.
- AI-driven approaches improve efficiency and scalability of cancer diagnostics.
- Image-based prediction reduces reliance on traditional molecular testing methods.